Hemab Reports Positive Sutacimig ISTH 2026 Data
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, July 14, 2026 Hemab Therapeutics presented new clinical and preclinical data at the International...
ISTH 2026
Advertisement
Hemab Reports Positive HMB-002 Data
CAMBRIDGE, Mass. and COPENHAGEN, Denmark, July 12, 2026 Hemab Therapeutics announced encouraging new clinical findings from its HMB-002 program...
Star Therapeutics to Present Phase 1/2 VGA039 Data at ISTH 2026
SOUTH SAN FRANCISCO, Calif., June 26, 2026 Star Therapeutics announced it will present complete safety and efficacy data from...
Novo Nordisk Showcases New Hemophilia Data Featuring Denecimig at ISTH 2026
PLAINSBORO, N.J., and BAGSVÆRD, Denmark, June 26, 2026 Novo Nordisk announced it will present new clinical and scientific findings...
Cadrenal Highlights Phase 2 CAD-1005 Trial in Prestigious ISTH 2026 Session
PONTE VEDRA, Fla., June 24, 2026 Cadrenal Therapeutics, Inc. announced that late-breaking clinical data from its Phase 2 study...
Advertisement
